1. Home
  2. GRFS vs LPX Comparison

GRFS vs LPX Comparison

Compare GRFS & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.66

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Logo Louisiana-Pacific Corporation

LPX

Louisiana-Pacific Corporation

HOLD

Current Price

$82.79

Market Cap

5.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
LPX
Founded
1940
1973
Country
Spain
United States
Employees
23800
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Forest Products
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.6B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
GRFS
LPX
Price
$8.66
$82.79
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$10.15
$110.17
AVG Volume (30 Days)
560.8K
1.3M
Earning Date
01-01-0001
05-20-2026
Dividend Yield
1.57%
1.44%
EPS Growth
N/A
N/A
EPS
N/A
2.08
Revenue
N/A
$2,708,000,000.00
Revenue This Year
$5.47
$7.35
Revenue Next Year
$4.92
$11.11
P/E Ratio
$18.67
$40.31
Revenue Growth
N/A
N/A
52 Week Low
$6.19
$73.42
52 Week High
$11.14
$102.86

Technical Indicators

Market Signals
Indicator
GRFS
LPX
Relative Strength Index (RSI) 38.13 41.16
Support Level $8.24 $80.17
Resistance Level $9.11 $94.01
Average True Range (ATR) 0.28 3.59
MACD -0.07 -0.81
Stochastic Oscillator 25.50 20.50

Price Performance

Historical Comparison
GRFS
LPX

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About LPX Louisiana-Pacific Corporation

Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.

Share on Social Networks: